Structure and function of RGD peptides derived from disintegrin proteins

Molecules and Cells

Volumn 19, Issue 2, 2005, Pages 205-211

  Kim, Jiun ^a   Hong, Sung Yu ^a   Park, Hye Seo ^a   Kim, Doo Sik ^a   Lee, Weontae ^a  

^a Yonsei University   (South Korea)

Author keywords

Disintegrin; Disulfide Bonded; NMR; RGD; Solution Structure

Indexed keywords

ALANYLGYLCYLGLYCYLASPARTYLASPARTIC ACID; ARGININE; ARGINYLGLYCYLASPARTIC ACID; CARBOXYL GROUP; CYCLOPEPTIDE; CYSTEINYLALANYLARGINYLGLYCYLASPARTYLASPARTYLCYSTEINE; DISINTEGRIN; GUANIDINE; MATRIX PROTEIN; UNCLASSIFIED DRUG; VITRONECTIN; ARGINYL-GLYCYL-ASPARTIC ACID; ASPARTIC ACID; OLIGOPEPTIDE; VITRONECTIN RECEPTOR;

ARTICLE; CONFORMATIONAL TRANSITION; DISULFIDE BOND; HUMAN; MOLECULAR MODEL; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; THROMBOCYTE AGGREGATION INHIBITION; CHEMISTRY; DRUG EFFECT; METABOLISM; NUCLEAR MAGNETIC RESONANCE; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION;

ARGININE; ASPARTIC ACID; DISINTEGRINS; HUMANS; INTEGRIN ALPHAVBETA3; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PLATELET AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; VITRONECTIN;

EID: 26044443505     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adler, M., Lazarus, R. A., Dennis, M. S., and Wagner, G. (1991) Solution structure of kistrin, a potent platelet aggregation inhibitor and GPIIb-IIIa antagonist. Science 253, 445-448.
2. Arap, W., Pasqualini, R., and Ruoslahti, E. (1998) Obtaining of measles virus haemagglutinin from strain L-16 grown in primary cell cultures. Science 279, 377-380.
3. Bax, A. and Davis D. G. (1985) The pulmonary hypertension of sclerosing agents is prevented by cyclooxygenase inhibitors. J. Magn. Reson. 65, 355-360.
4. Bogdanowich-Knipp, S. J., Jois, D. S., and Siahaan, T. J. (1999) The effect of conformation on the solution stability of linear vs. cyclic RGD peptides. J. Pept. Res. 53, 523-529.
5. Bogdanowich-Knipp, S. J., Chakrabarti, S., Williams, T. D., Dillman, R. K., and Siahaan, T. J. (1999) Solution stability of linear vs. cyclic RGD peptides. J. Pept. Res. 53, 530-541.
6. Brooks, P. C., Stromblad, S., Klemle, R., Visscher, D., Sarkar, F. H., et al. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85, 683-693.
7. Calvete, J. J., Fox, J. W., Agelan, A., Niewiarowski, S., and Marcinkiewicz, C. (2002) The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on αIIbβ3, αvβ3, and α5β1 integrins. Biochemistry 41, 2014-2021.
8. Chung, K. H., Kim, S. H., Han, K. Y., Sohn, Y. D., Chang, S. I., et al. (2003) Inhibitory effect of salmosin, a Korean snake venom-derived disintegrin, on the integrin alphav-mediated proliferation of SK-Mel-2 human melanoma cells. J. Pharm. Pharmacol. 55, 1577-1582.
9. Davis, D. G. and Bax, A. J. (1985) 15N-labeled Escherichia coli tRNAfMet, tRNAGlu, tRNATyr, and tRNAPhe. Double resonance and two-dimensional NMR of N1-labeled pseudouridine. J. Biol. Chem. 107, 2820-2821.
10. Driscoll, P. C., Gronenborn, A. M., Beress, L., and Clore, G. M. (1989a) Determination of the three-dimensional solution structure of the antihypertensive and antiviral protein BDS-I from the sea anemone Anemonia sulcata: a study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing. Biochemistry 28, 2188-2198.
11. Driscoll, P. C., Gronenborn, A. M., and Clore, G. M. (1989b) A proton nuclear magnetic resonance study of the antihypertensive and antiviral protein BDS-I from the sea anemone Anemonia sulcata: sequential and stereospecific resonance assignment and secondary structure. Biochemistry 28, 2178-2187.
12. Fujii, Y., Okuda, D., Fujimoto, Z., Horii, K., Morita, T., et al. (2003) Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J. Mol. Biol. 332, 1115-1122.
13. Goddard, T. D. and Kneller, D. G. (2002) SPARKY 3, University of California, San Francisco.
14. Gould, R. J., Polokoff, M. A., Friedman, P. A., Huang, T. F., Holt, J. C., et al. (1990) Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Biol. Med. 195, 168-171.
15. Kim, H.-Y., Kim, Y.-M., Shin, Y.-K., Park, S.-H., and Lee, W. (2004) Solution structure of the cytoplasmic domain of human CD99 type I. Mol. Cells 18, 1, 24-29.
16. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 14, 29-31.
17. Lakovski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. J. Appl. Crystallogr. 26, 191-205.
18. Lee, W., Moore, C. H., Watt, D. D., and Krishna, N. R. (1994) Solution structure of the variant-3 neurotoxin from Centruroides sculpturatus Ewing. Eur. J. Biochem. 219, 89-95.
19. Marcinkiewicz, C., Calvete, J. J., Marcinkiewicz, M. M., Raida, M., Vijay-Kumar, S., et al. (1999a) EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits α4 and α5 integrins in an RGD-independent manner. J. Biol. Chem. 274, 12468-12473.
20. Marcinkiewicz, C., Calvete, J. J., Vijay-Kumar, S., Marcinkiewicz, M. M., Raida, M., et al. (1999b) Structural and functional characterization of EMF10, a heterodimeric disintegrin from Eristocophis macmahoni venom that selectively inhibits α5β1 integrin. Biochemistry 38, 13302-13309.
21. Marcinkiewicz, C., Taooka, Y., Yokosaki, Y., Calvete, J. J., Marcinkiewicz, M. M., et al. (2000) Inhibitory effect of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin α9β1 with VCAM, tenascin-C, and osteopontin. J. Biol. Chem. 275, 31930-31937.
22. 3 integrins. FEBS. Lett. 391, 139-143.
23. McLane, M. A., Marcinkiewicz, C., Vijay-Kumar, S., Wierzbicka-Patynowski, I., and Niewiarowski, S. (1998) Viper venom disintegrins and related molecules. Proc. Soc. Exptl. Biol. Med. 219, 109-119.
24. Niewiarowski, S., Marcinkiewicz, C., Wierzbicka-Patynowski, I., McLane, M. A., and Calvete, J. J. (2002) Structure and function of disintegrins and C-lectins: viper venom proteins modulating cell adhesion; in Perspectives in Molecular Toxinology, Ménez, A. (ed.), pp. 327-340, Wiley, New York.
25. Nilges, M., Clore, G. M., and Gronenborn, A. M. (1988a) Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding. FEBS Lett. 239, 129-136.
26. Nilges, M., Gronenborn, A. M., Brunger, A. T., and Clore, G. M. (1988b) Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. Protein Eng. 1, 127-138.
27. Paz Moreno-Murciano, M., Monleon, D., Marcinkiewicz, C., Calvete, J. J., and Celda, B. (2003) NMR solution structure of the non-RGD disintegrin obtustatin. J. Mol. Biol. 329, 135-145.
28. Piotto, M., Saudek, V., and Sklenar, V. J. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661.
29. Rance, M., Soerensen, O. W., Bodehausen, G., Wagner, G., Ernst, R. R., et al. (1983a) Protein conformation and proton nuclear-magnetic-resonance chemical shifts. Eur. J. Biochem. 137, 445-454.
30. Rance, M., Sorensen, O. W., Bodenhausen, G., Wagner, G., Ernst, R. R., et al. (1983b) Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117, 479.
31. Saudek, V., Atkinson, R. A., and Pelton, J. T. (1991) Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 30, 7369-7372.
32. Scarborough, R. M., Rose, J. W., Hsu, M. A., Phillips, D. R., Fried, V. A., et al. (1991) Barbourin; A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus M. barbouri. J. Biol. Chem. 266, 9359-9362.
33. Senn, H. and Klaus, W. (1993) The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GPIIb-IIIa receptor. J. Mol. Biol. 232, 907-925.
34. Shin, J., Hong, S. Y., Chung, K., Kang, I., Jang, Y., et al. (2003) Solution structure of a novel disintegrin, salmosin from Ag-kistrondon halys Venom. Biochemistry 42, 14408-14415.
35. 1H NMR spectroscopy and simulated annealing calculations. Int. J. Pept. Protein 48, 220-228.
36. Trikha, M., De Clerk, Y. A., and Markland, F. S. (1994) Contortrostatin, a snake venom disintegrin, inhibits β1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer 54, 4993-4998.
37. Wagner, G., Braun, W., Havel, T. F., Schaumann, T., Go, N., et al. (1987) Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor determined using two different algorithms, DISGEO and DISMAN. J. Mol. Biol. 196, 611-639.
38. Wüthrich, K. (1986) NMR of proteins and nucleic acids, Wiley, New York.
39. Wüthrich, K., Billeter, M., and Braun, W. (2003) Dissection of heteronuclear NMR experiments for studies of magnetization transfer efficiencies. J. Magn. Reson. 165, 89-94.
40. Yamamoto, M., Fisher, J. E., Gentile, M., Seedor, J. G., Leu, C. T., et al. (1998) Obtaining of measles virus haemagglutinin from strain L-16 grown in primary cell cultures. Endocrinology 139, 1411-1419.